Table of Contents
Overview
New York, NY – March 11, 2026 – The global EPA and DHA market is projected to reach around USD 4.0 billion by 2034, rising from USD 2.0 billion in 2024, with steady growth driven by increasing consumer focus on health and preventive nutrition. North America currently represents a significant share of the market, accounting for 38.7% and generating approximately USD 0.7 billion in revenue.
EPA and DHA are essential long-chain omega-3 fatty acids primarily sourced from marine fish and microalgae. These nutrients play a crucial role in supporting cardiovascular health, cognitive function, vision development, and inflammation management. EPA is mainly associated with heart health and anti-inflammatory benefits, while DHA is critical for brain performance and eye health. Since the human body produces only limited amounts of these fatty acids, they are widely consumed through dietary supplements, fortified foods, and specialized nutrition products.
The market comprises a broad ecosystem of producers and suppliers developing omega-3 ingredients from traditional marine sources and emerging algae-based alternatives. Innovation and sustainability are key growth drivers, supported by significant funding in omega-3 biotechnology. Mara Renewables secured USD 9.1 million from S2G Investments to expand algae-based omega-3 production. MiAlgae raised USD 18.5 million to scale its microalgae-derived omega-3 product, while Algiecel secured €6.5 million in equity funding to expand its microalgae platform.
Slàinte raised £14 million to produce omega-3 from whisky waste, and MiAlgae also secured an additional £14 million in new funding. Furthermore, UK biotechnology initiatives received a £20 million funding boost to support omega-3 innovation. Growing demand across all age groups, combined with advances in algae fermentation and circular production methods, continues to strengthen the long-term outlook for EPA and DHA solutions.
➤ Click the sample report link for complete industry insights: https://market.us/report/epa-and-dha-market/request-sample/
Key Takeaways
- The Global EPA And DHA Market is expected to be worth around USD 4.0 billion by 2034, up from USD 2.0 billion in 2024, and is projected to grow at a CAGR of 7.2% from 2025 to 2034.
- EPA And DHA Market sees Fish Oil sources dominating with 67.2% share due to availability.
- EPA And DHA Market reports Capsules and Soft gels leading forms holding 56.4% preference globally.
- EPA And DHA Market highlights Dietary Supplements application dominating demand with 59.1% market share overall.
- North America leads the EPA and DHA market with 38.7% dominance, generating USD 0.7 Bn revenue.
➤ Directly purchase a copy of the report – https://market.us/purchase-report/?report_id=174163
Market Segments
By Source Analysis
Fish oil is the leading source in the EPA and DHA market, contributing about 67.2% of global demand. Its dominance is mainly due to the naturally high concentration of omega-3 fatty acids and the long-established supply chains built around marine fisheries. Species such as anchovy, sardine, and mackerel are widely harvested to ensure consistent large-scale production. Fish oil also benefits from strong scientific and clinical evidence supporting its role in heart health, brain function, and inflammation management.
Compared with alternatives such as algal oil or krill oil, fish oil remains more cost-effective, which supports its use in large-scale commercial products. Continuous advancements in purification and refining technologies, along with long-standing consumer trust, help maintain its strong position in global EPA and DHA ingredient production.
By Form Analysis
Capsules and soft gels represent the most popular form in the EPA and DHA market, accounting for approximately 56.4% of total consumption. Their popularity is largely driven by convenience, ease of swallowing, and precise dosage control, which are important for maintaining regular omega-3 intake. These formats also help mask the natural odor and taste of fish oil, improving consumer acceptance.
Another advantage is their ability to protect the ingredients from oxidation, ensuring longer shelf stability compared to liquid formulations. Capsules and soft gels are portable and easy to integrate into daily routines, making them appealing to both working professionals and older consumers. From a manufacturing perspective, they are compatible with large-scale encapsulation technologies and allow product differentiation through size, color, and coating options.
By Application Analysis
Dietary supplements are the largest application segment in the EPA and DHA market, accounting for about 59.1% of total demand. Increasing awareness of preventive healthcare and the benefits of omega-3 fatty acids has driven consumers to incorporate these nutrients into daily wellness routines. EPA and DHA supplements are commonly associated with supporting cardiovascular health, cognitive performance, eye health, and joint mobility. Demand is further strengthened by aging populations and growing interest in long-term health maintenance rather than treatment-based solutions.
Healthcare professionals frequently recommend omega-3 supplements, which also boosts consumer confidence. Additionally, supplements are widely available through pharmacies, health stores, and online platforms, making them highly accessible. Compared with pharmaceutical or functional food applications, supplements allow faster product development and easier market entry.
Regional Analysis
The EPA and DHA market shows notable regional differences in demand and growth patterns. North America leads the global market, holding a 38.7% share and generating about USD 0.7 billion in revenue. Strong consumer awareness of omega-3 health benefits, widespread use of dietary supplements, and well-developed retail and online distribution networks drive this dominance.
Europe follows with stable demand supported by preventive healthcare practices, aging populations, and regular consumption of omega-3 products in daily nutrition. Meanwhile, the Asia-Pacific region is experiencing rising demand, as urbanization, higher disposable incomes, and growing interest in wellness products drive omega-3 adoption across major economies.
In the Middle East & Africa, market expansion is gradual but improving, driven by better access to supplements and rising health awareness. Latin America is also emerging as a growth opportunity as consumers become more aware of heart and brain health benefits, particularly due to increased marketing efforts and educational campaigns highlighting the advantages of omega-3 fatty acids.
Top Use Cases
- Heart Health Support ❤️: EPA and DHA are widely used to support heart health. These omega-3 fats can help lower triglyceride levels in the blood and reduce inflammation in blood vessels. They may also help maintain normal heart rhythm and lower the risk of heart disease and stroke when included in a healthy diet. Because of these benefits, doctors often recommend omega-3 intake through fish or supplements for cardiovascular wellness.
- Brain Function and Memory 🧠: DHA, in particular, is an important structural component of brain cells. EPA and DHA are used to support cognitive performance, learning ability, and memory. Research shows that omega-3 intake can improve blood flow in the brain and may help maintain cognitive function, especially in older adults.
- Eye and Vision Health 👁️: DHA plays an important role in maintaining healthy vision because it is a major component of the retina. Adequate DHA intake may support eye development and help reduce some eye problems such as dry eye by lowering inflammation.
- Baby Development During Pregnancy 👶: EPA and DHA are important during pregnancy because they support fetal brain and eye development. Studies show these omega-3 fats contribute to proper neurological and retinal development in babies. For this reason, prenatal nutrition products often include DHA.
- Reducing Inflammation and Joint Pain 🦴: EPA and DHA help control inflammation in the body. This makes them useful for people with conditions like arthritis or joint pain. By lowering inflammatory markers, these omega-3 fatty acids may help reduce stiffness and discomfort in joints.
- Supporting Healthy Aging and Immunity 🌿: Omega-3 fats are often used to support healthy aging. They help reduce inflammation and oxidative stress in the body, which are factors linked to aging and chronic disease. Regular intake of EPA and DHA has also been associated with better immune function and overall wellness.
Notable Company Developments
- In July 2024, KD Pharma Group announced its acquisition of the Marine Lipids business from DSM-Firmenich. This deal includes the MEG-3® fish oil omega-3 brand and production facilities in Peru and Canada. The acquisition was designed to strengthen KD Pharma’s position in the EPA and DHA supply chain and expand its omega-3 manufacturing capabilities for food, supplement, and pharmaceutical markets.
- In March 2024, DSM-Firmenich collaborated with SCN BestoCo to create omega-3 gummy supplements. The company used its Life’s® OMEGA O33-P10 powder technology, which protects EPA and DHA within a special coating. This enables gummies to deliver more than 400 mg of EPA+DHA per serving while maintaining taste stability and improving product quality.
- In 2024, ADM continued expanding its Onavita™ omega-3 ingredient portfolio, which includes plant-based DHA and EPA blends made from microalgae. These ingredients are designed to help manufacturers create clean-label, non-GMO omega-3 products for heart, brain, and eye health. The algae-based source also provides a sustainable alternative to traditional fish oil.
Conclusion
The EPA and DHA market continues to grow as consumers increasingly focus on preventive healthcare and daily nutrition. These omega-three fatty acids are widely recognized for supporting heart health, brain function, vision, and overall wellness. Demand is rising across supplements, functional foods, and specialized nutrition products as people look for convenient ways to improve their diet.
Innovation in sustainable production, including algae-based sources and improved extraction technologies, is also shaping the industry’s future. Companies are investing in cleaner, more reliable supply chains to meet global demand. With growing awareness of nutritional benefits and expanding product applications, the EPA and DHA market is expected to remain an important part of the global health and nutrition landscape.
Discuss your needs with our analyst
Please share your requirements with more details so our analyst can check if they can solve your problem(s)
